IPV Vaccines Market, by Vaccine Brand (POLIOVAC, SHANIPV, POLIORIX, IPOL/IMOVAX, And POLYMILEX), by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published: March 9, 2022 |

Coherent Market Insights | 220 Pages | Delivery time: 2-3 business days

Price

Description
Table of Contents

Add to Compare

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at US$ 160 Mn in 2021 and is expected to increase to US$ 240 Mn by 2028, registering a CAGR of 8.5% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2019, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

Global IPV Vaccines Market, by Vaccine Brand:
Poliovac (Pfs/Sd)
Shanipv
Poliorix
Ipol/Imovax
Polymilex
Global IPV Vaccines Market, by Distribution Channel:
Private
Public
Global IPV Vaccines Market, by Region:
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles:
- GlaxoSmithKline Plc*
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Sanofi S.A.
- Serum Institute of India Pvt. Ltd.
- PT Bio Farma
- AJ Vaccines

"" marked represents similar segmentation in other categories in the respective section.*

Product Code: CMI4965

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Vaccine Brand
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
IPV Vaccine Country wise Adoption Status
IPV Vaccines Supplied by UNICEF for Gavi
Polio Vaccination Entry and Exit Requirements
Contribution of Regulated Markets (U.S., EU5, and Others)
Market Trends
Regulatory Scenario
Pipeline Analysis
Acquisitions
PEST Analysis
Public and Private Pricing - IPV Vaccine
Epidemiology

4. Global IPV Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact of COVID-19 on Healthcare market
COVID-19 Epidemiology

5. Global IPV Vaccines Market, By Vaccine Brand, 2021 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
Poliovac (PFS/SD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Shanipv
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Poliorix
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Ipol/Imovax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Polymilex
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global IPV Vaccines Market, By Distribution Channel, 2021 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global IPV Vaccines Market, By Region, 2021 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2028
North America
- Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- GlaxoSmithKline Plc
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Sanofi S.A.
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Serum Institute of India Pvt. Ltd.
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- PT Bio Farma
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- AJ Vaccines
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies